The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oral Vaccination Market Research Report 2025
Synopsis
Oral vaccines have several attractive features compared with parenteral vaccines, but studies on their use have been limited almost exclusively to protection against mucosally transmitted pathogens.
Global Oral Vaccination market is projected to reach US$ 3592.1 million in 2029, increasing from US$ 2510 million in 2022, with the CAGR of 5.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oral Vaccination market research.
The oral vaccination market is primarily driven by the advantages it offers in terms of ease of administration, increased patient compliance, and cost-effectiveness compared to traditional injectable vaccines. Oral vaccines provide a non-invasive and painless immunization method, particularly beneficial for pediatric and elderly populations. Additionally, their potential to elicit both systemic and mucosal immunity enhances protection against pathogens that enter the body through mucosal surfaces, such as the respiratory and gastrointestinal tracts, further fueling their adoption. However, the market also faces challenges, including the complex formulation and delivery of oral vaccines, which may affect their stability and efficacy. Developing vaccines that can withstand acidic environments and enzymatic degradation in the gastrointestinal tract poses significant scientific and manufacturing challenges. Moreover, gaining regulatory approvals and ensuring public acceptance of oral vaccines may require extensive clinical data and educational efforts to dispel misconceptions about their safety and efficacy. To overcome these challenges, the industry is focused on research and innovation to improve oral vaccine formulation and delivery technologies. Collaborations between vaccine developers, research institutions, and regulatory authorities are crucial in driving the growth of the oral vaccination market and expanding access to effective and accessible immunization options, particularly in regions with limited healthcare infrastructure.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Oral Vaccination market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
Emergent BioSolutions
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Segment by Type
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Other
Segment by Application
Public
Private
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Oral Vaccination report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Oral vaccines have several attractive features compared with parenteral vaccines, but studies on their use have been limited almost exclusively to protection against mucosally transmitted pathogens.
Global Oral Vaccination market is projected to reach US$ 3592.1 million in 2029, increasing from US$ 2510 million in 2022, with the CAGR of 5.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oral Vaccination market research.
The oral vaccination market is primarily driven by the advantages it offers in terms of ease of administration, increased patient compliance, and cost-effectiveness compared to traditional injectable vaccines. Oral vaccines provide a non-invasive and painless immunization method, particularly beneficial for pediatric and elderly populations. Additionally, their potential to elicit both systemic and mucosal immunity enhances protection against pathogens that enter the body through mucosal surfaces, such as the respiratory and gastrointestinal tracts, further fueling their adoption. However, the market also faces challenges, including the complex formulation and delivery of oral vaccines, which may affect their stability and efficacy. Developing vaccines that can withstand acidic environments and enzymatic degradation in the gastrointestinal tract poses significant scientific and manufacturing challenges. Moreover, gaining regulatory approvals and ensuring public acceptance of oral vaccines may require extensive clinical data and educational efforts to dispel misconceptions about their safety and efficacy. To overcome these challenges, the industry is focused on research and innovation to improve oral vaccine formulation and delivery technologies. Collaborations between vaccine developers, research institutions, and regulatory authorities are crucial in driving the growth of the oral vaccination market and expanding access to effective and accessible immunization options, particularly in regions with limited healthcare infrastructure.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Oral Vaccination market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
Emergent BioSolutions
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Segment by Type
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Other
Segment by Application
Public
Private
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Oral Vaccination report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Oral Vaccination Market Overview
1.1 Product Overview and Scope of Oral Vaccination
1.2 Oral Vaccination Segment by Type
1.2.1 Global Oral Vaccination Market Value Comparison by Type (2023-2029)
1.2.2 Rotavirus Vaccine
1.2.3 Cholera Vaccine
1.2.4 Oral Polio Vaccine
1.2.5 Other
1.3 Oral Vaccination Segment by Application
1.3.1 Global Oral Vaccination Market Value by Application: (2023-2029)
1.3.2 Public
1.3.3 Private
1.4 Global Oral Vaccination Market Size Estimates and Forecasts
1.4.1 Global Oral Vaccination Revenue 2018-2029
1.4.2 Global Oral Vaccination Sales 2018-2029
1.4.3 Global Oral Vaccination Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Oral Vaccination Market Competition by Manufacturers
2.1 Global Oral Vaccination Sales Market Share by Manufacturers (2018-2023)
2.2 Global Oral Vaccination Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Oral Vaccination Average Price by Manufacturers (2018-2023)
2.4 Global Oral Vaccination Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Oral Vaccination, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Vaccination, Product Type & Application
2.7 Oral Vaccination Market Competitive Situation and Trends
2.7.1 Oral Vaccination Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Vaccination Players Market Share by Revenue
2.7.3 Global Oral Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Vaccination Retrospective Market Scenario by Region
3.1 Global Oral Vaccination Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Oral Vaccination Global Oral Vaccination Sales by Region: 2018-2029
3.2.1 Global Oral Vaccination Sales by Region: 2018-2023
3.2.2 Global Oral Vaccination Sales by Region: 2024-2029
3.3 Global Oral Vaccination Global Oral Vaccination Revenue by Region: 2018-2029
3.3.1 Global Oral Vaccination Revenue by Region: 2018-2023
3.3.2 Global Oral Vaccination Revenue by Region: 2024-2029
3.4 North America Oral Vaccination Market Facts & Figures by Country
3.4.1 North America Oral Vaccination Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Oral Vaccination Sales by Country (2018-2029)
3.4.3 North America Oral Vaccination Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral Vaccination Market Facts & Figures by Country
3.5.1 Europe Oral Vaccination Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Oral Vaccination Sales by Country (2018-2029)
3.5.3 Europe Oral Vaccination Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Vaccination Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Vaccination Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Oral Vaccination Sales by Country (2018-2029)
3.6.3 Asia Pacific Oral Vaccination Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oral Vaccination Market Facts & Figures by Country
3.7.1 Latin America Oral Vaccination Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Oral Vaccination Sales by Country (2018-2029)
3.7.3 Latin America Oral Vaccination Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Vaccination Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Vaccination Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Oral Vaccination Sales by Country (2018-2029)
3.8.3 Middle East and Africa Oral Vaccination Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Vaccination Sales by Type (2018-2029)
4.1.1 Global Oral Vaccination Sales by Type (2018-2023)
4.1.2 Global Oral Vaccination Sales by Type (2024-2029)
4.1.3 Global Oral Vaccination Sales Market Share by Type (2018-2029)
4.2 Global Oral Vaccination Revenue by Type (2018-2029)
4.2.1 Global Oral Vaccination Revenue by Type (2018-2023)
4.2.2 Global Oral Vaccination Revenue by Type (2024-2029)
4.2.3 Global Oral Vaccination Revenue Market Share by Type (2018-2029)
4.3 Global Oral Vaccination Price by Type (2018-2029)
5 Segment by Application
5.1 Global Oral Vaccination Sales by Application (2018-2029)
5.1.1 Global Oral Vaccination Sales by Application (2018-2023)
5.1.2 Global Oral Vaccination Sales by Application (2024-2029)
5.1.3 Global Oral Vaccination Sales Market Share by Application (2018-2029)
5.2 Global Oral Vaccination Revenue by Application (2018-2029)
5.2.1 Global Oral Vaccination Revenue by Application (2018-2023)
5.2.2 Global Oral Vaccination Revenue by Application (2024-2029)
5.2.3 Global Oral Vaccination Revenue Market Share by Application (2018-2029)
5.3 Global Oral Vaccination Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Oral Vaccination Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck Oral Vaccination Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Oral Vaccination Sales, Revenue and Gross Margin (2018-2023)
6.2.4 GSK Oral Vaccination Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Oral Vaccination Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sanofi Oral Vaccination Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Lanzhou Institute
6.4.1 Lanzhou Institute Corporation Information
6.4.2 Lanzhou Institute Description and Business Overview
6.4.3 Lanzhou Institute Oral Vaccination Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Lanzhou Institute Oral Vaccination Product Portfolio
6.4.5 Lanzhou Institute Recent Developments/Updates
6.5 Serum Institute
6.5.1 Serum Institute Corporation Information
6.5.2 Serum Institute Description and Business Overview
6.5.3 Serum Institute Oral Vaccination Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Serum Institute Oral Vaccination Product Portfolio
6.5.5 Serum Institute Recent Developments/Updates
6.6 Valneva
6.6.1 Valneva Corporation Information
6.6.2 Valneva Description and Business Overview
6.6.3 Valneva Oral Vaccination Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Valneva Oral Vaccination Product Portfolio
6.6.5 Valneva Recent Developments/Updates
6.7 Shanghai United Cell
6.6.1 Shanghai United Cell Corporation Information
6.6.2 Shanghai United Cell Description and Business Overview
6.6.3 Shanghai United Cell Oral Vaccination Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Shanghai United Cell Oral Vaccination Product Portfolio
6.7.5 Shanghai United Cell Recent Developments/Updates
6.8 Bibcol
6.8.1 Bibcol Corporation Information
6.8.2 Bibcol Description and Business Overview
6.8.3 Bibcol Oral Vaccination Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Bibcol Oral Vaccination Product Portfolio
6.8.5 Bibcol Recent Developments/Updates
6.9 Emergent BioSolutions
6.9.1 Emergent BioSolutions Corporation Information
6.9.2 Emergent BioSolutions Description and Business Overview
6.9.3 Emergent BioSolutions Oral Vaccination Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Emergent BioSolutions Oral Vaccination Product Portfolio
6.9.5 Emergent BioSolutions Recent Developments/Updates
6.10 Vabiotech
6.10.1 Vabiotech Corporation Information
6.10.2 Vabiotech Description and Business Overview
6.10.3 Vabiotech Oral Vaccination Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Vabiotech Oral Vaccination Product Portfolio
6.10.5 Vabiotech Recent Developments/Updates
6.11 Tiantan Biological
6.11.1 Tiantan Biological Corporation Information
6.11.2 Tiantan Biological Oral Vaccination Description and Business Overview
6.11.3 Tiantan Biological Oral Vaccination Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Tiantan Biological Oral Vaccination Product Portfolio
6.11.5 Tiantan Biological Recent Developments/Updates
6.12 EuBiologics
6.12.1 EuBiologics Corporation Information
6.12.2 EuBiologics Oral Vaccination Description and Business Overview
6.12.3 EuBiologics Oral Vaccination Sales, Revenue and Gross Margin (2018-2023)
6.12.4 EuBiologics Oral Vaccination Product Portfolio
6.12.5 EuBiologics Recent Developments/Updates
6.13 Panacea Biotec Ltd
6.13.1 Panacea Biotec Ltd Corporation Information
6.13.2 Panacea Biotec Ltd Oral Vaccination Description and Business Overview
6.13.3 Panacea Biotec Ltd Oral Vaccination Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Panacea Biotec Ltd Oral Vaccination Product Portfolio
6.13.5 Panacea Biotec Ltd Recent Developments/Updates
6.14 Bio-Med
6.14.1 Bio-Med Corporation Information
6.14.2 Bio-Med Oral Vaccination Description and Business Overview
6.14.3 Bio-Med Oral Vaccination Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Bio-Med Oral Vaccination Product Portfolio
6.14.5 Bio-Med Recent Developments/Updates
6.15 Halfkin Bio-Pharmaceuticals
6.15.1 Halfkin Bio-Pharmaceuticals Corporation Information
6.15.2 Halfkin Bio-Pharmaceuticals Oral Vaccination Description and Business Overview
6.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccination Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccination Product Portfolio
6.15.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Vaccination Industry Chain Analysis
7.2 Oral Vaccination Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Vaccination Production Mode & Process
7.4 Oral Vaccination Sales and Marketing
7.4.1 Oral Vaccination Sales Channels
7.4.2 Oral Vaccination Distributors
7.5 Oral Vaccination Customers
8 Oral Vaccination Market Dynamics
8.1 Oral Vaccination Industry Trends
8.2 Oral Vaccination Market Drivers
8.3 Oral Vaccination Market Challenges
8.4 Oral Vaccination Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
